PubMed Health⌕ Search

PubMed · 15977286

Multiple imputation under Bayesianly smoothed pattern-mixture models for non-ignorable drop-out.

Abstract

Conventional pattern-mixture models can be highly sensitive to model misspecification. In many longitudinal studies, where the nature of the drop-out and the form of the population model are unknown, interval estimates from any single pattern-mixture model may suffer from undercoverage, because uncertainty about model misspecification is not taken into account. In this article, a new class of Bayesian random coefficient pattern-mixture models is developed to address potentially non-ignorable drop-out. Instead of imposing hard equality constraints to overcome inherent inestimability problems in pattern-mixture models, we propose to smooth the polynomial coefficient estimates across patterns using a hierarchical Bayesian model that allows random variation across groups. Using real and simulated data, we show that multiple imputation under a three-level linear mixed-effects model which accommodates a random level due to drop-out groups can be an effective method to deal with non-ignorable drop-out by allowing model uncertainty to be incorporated into the imputation process.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hakan Demirtas. 2005-08-15. Multiple imputation under Bayesianly smoothed pattern-mixture models for non-ignorable drop-out.. https://doi.org/10.1002/sim.2117

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Differential pharmacology of atypical antipsychotics: clinical implications.

PURPOSE: Pharmacology of atypical antipsychotics and the clinical implications are reviewed. SUMMARY: Psychiatric disorders, such as schizophrenia and bipolar disorder, are often associated with poor outcomes. Atypical antipsychotics have become the standard of care for these disorders, and multiple agents have demonstrated efficacy for both acute and maintenance therapy. As a result of their differential pharmacologic properties, atypical antipsychotics have diverse clinical profiles, resulting in different liabilities for specific adverse events. These effects can, in turn, have an adverse impact on patient functionality, adherence to therapy, and overall health. CONCLUSION: Atypical antipsychotics have distinct pharmacological profiles which result in clinically meaningful differences in adverse effects. Clinicians should have a wide choice of agents available with which to optimize outcomes in the majority of patients with psychiatric disorders.

Antipsychotic Agents↗